Welcome back to Conversations With Carevoyance, a series dedicated to highlighting healthcare and MedTech vendors, thought leaders, and innovators across the healthcare industry. Today, we’re chatting with Dr. Dan Ladizinsky of Suturegard.

Founded in 2017, Suturegard is a medical technology solutions company with a primary product that allows surgeons to close wounds more quickly and easily with fewer sutures and in such a way that reduces or removes the need for skin grafts and reduces damage to skin.

Welcome back to Conversations With Carevoyance, a series dedicated to highlighting healthcare and MedTech vendors, thought leaders, and innovators across the healthcare industry. Today, we’re chatting with Lisa Bichsel, owner of Bichsel Medical Marketing Group.

Founded in 2014, Bichsel Medical Marketing Group or BMMG builds and executes marketing strategies for medical device and biotech companies. Most of their clients are startups, so Bichsel and her team help them with scalable marketing, advertising, PR, and other critical aspects of commercialization as they work toward their exit strategy.

​Welcome to the first installment of Conversations With Carevoyance, a new series dedicated to highlighting healthcare and MedTech vendors, thought leaders, and innovators. Today, we’re thrilled to share an interview with Gavin Doree, Vice President of Sales and Marketing at Exalenz Bioscience.
​
Founded in 2006, Exalenz is one of two commercially available 13C Urea Breath tests in the United States for the diagnosis and confirmation of eradication of Helicobacter pylori (H. pylori). Specializing in noninvasive modalities for different GI and liver function diagnostics, Exalenz Bioscience’s patented BreathID technology delivers immediate results with industry leading specificity and sensitivity.